New to Meducation?
Sign up
Already signed up? Log In
view moderators

LungNeoplasms

Category

Preview
11
315

Lung cancer diagnosis

This slideshow gives a good summary of the diagnosis of lung cancer.  
Sarah Goodall
over 10 years ago
13
1
18

Q&A Session on The Emerging Role of Molecular Markers in NSCLC: a Webinar by Dr. Nathan Pennell (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Q&amp;A Session following webinar with Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, on the use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
0
1
24

Q&A Session on The Emerging Role of Molecular Markers in NSCLC: a Webinar by Dr. Nathan Pennell (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Q&amp;A Session following webinar with Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, on the use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
3
2
35

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
4
1
22

ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
9
1
47

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
10
1
46

Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
11
1
63

IInterview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
12
1
39

Interview with Dr. Matthew Horton, Pathologist Part 3: Defining Lung Cancer with Molecular Markers (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses new approaches in molecular profiling of lung cancers.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
13
1
20

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (audio)

<p><span style="font-family: Times; font-size: medium;"> </span></p <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;"><span style="font-family: Times; font-size: medium; white-space: normal;"> </span></span></span></p <span style="font-family: arial, sans, sans-serif; font-size: small;" <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><span style="font-family: arial, sans, sans-serif; font-size: small;"><span style="font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></span></p </div </span <p>&nbsp;</p </div <p>&nbsp;</p>  
Howard (Jack) West, MD
almost 9 years ago
0
1
26

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
5
1
24

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
almost 9 years ago
6
1
17

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
almost 9 years ago
7
1
24

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
almost 9 years ago
8
1
19

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
almost 9 years ago
9
1
53

Second Line Treatment of Adv NSCLC: What Drugs and When? (audio)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
10
1
58

Second Line Treatment of Adv NSCLC: What Drugs and When? (video)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
1
1
24

Treating Lung Cancer: Past, Present, and Future (Audio)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
almost 9 years ago
2
2
22

Treating Lung Cancer: Past, Present, and Future (Video)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
almost 9 years ago
11
1
29

Diagnosis and Staging of Lung Cancer: A Pulmonologist's Perspective (Audio)

This slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.  
Howard (Jack) West, MD
almost 9 years ago